Research On Cpaaudit Responsibility In Illegal Information Disclosure Of Pharmaceutical Enterprises Under The Background Of Registration System

Since the third Plenary session of the 18 th CPC Central Committee initiated the reform of the stock issuance registration system,China passed the newly revised Securities Law on December 28,2019,which represents the abolition of the approval system at the legislative level and the formal transition to the registration system.not only take information disclosure as the core of the registration system.At the same time,it improves the liability system of the injured party’s class action after the event,and tries to consolidate the regulatory responsibilities of all regulatory subjects,including certified public accountants.Then,the "opinions of the General Office of the State Council on further standardizing the financial audit order and promoting the healthy development of the CPA profession"(hereinafter referred to as "opinions")issued by the General Office of the State Council in July 2021,further clarify the need to promote the healthy development of CPA business,but also more clearly clarify the social responsibility of CPA as the "gatekeeper" of the industry.Especially in recent years,with the continuous development and growth of China’s capital market,various forms of information disclosure violations emerge in endlessly,which not only brings serious losses to the majority of investors,but also imposes unbearable audit responsibility on the audit profession.Therefore,it is necessary to study the supervision responsibility of auditors in the violation of information disclosure of listed companies.This paper chooses Kangmei Pharmaceutical as the research object,on the one hand,the pharmaceutical industry is related to people’s livelihood,the more important reason is that its information disclosure violation cases have distinct characteristics.As an enterprise that directly causes delisting risk due to financial fraud in the environment of registration system,mechanisms such as class action have played an important role in the supervision of *ST Camry information disclosure.This paper starts with the general situation of the violation of information disclosure in the pharmaceutical industry,reviews the case of illegal information disclosure of Camry Pharmaceutical Industry under the background of registration system,and analyzes the impact of *ST Camry illegal information disclosure on CPA audit responsibility.On this basis,this paper makes a deep analysis of the reasons and identification of CPA’s audit responsibility,and then judges the appropriateness of its audit responsibility.Finally,from the perspective of CPA audit responsibility caused by Kangmei’s illegal information disclosure,closely combined with the information disclosure of enterprises and the supervision responsibilities of intermediary agencies,this paper explores how CPA can prevent the serious impact of joint and several liability on individuals and accounting firms under the background of registration system,which will be of strategic and practical significance to the long-standing development of the whole audit profession.